Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

doi:10.1084/jem.162.6.1745

This Article

	Full Text (PDF, 1047K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Ljunggren, H. G.
	Articles by Karre, K.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Ljunggren, H. G.
	Articles by Karre, K.


Social Bookmarking

	What's this?

ARTICLES

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

HG Ljunggren and K Karre

Three independent variants with a profound reduction of cell surface H- 2 have been selected from the C57BL/6 mouse-derived RBL-5 and EL-4 T lymphomas. After subcutaneous inoculation of low cell doses in syngeneic mice, the H-2- variants failed to grow out, whereas the H-2+ control lines showed progressive growth. No difference in growth rate or cloning efficiency was detectable in tissue culture. The in vivo difference in tumor outgrowth was analyzed in detail for one of the H-2- low lines. The outgrowth difference remained after the H-2-low variant and the control line had been injected subcutaneously in opposite flanks of the same mouse, and it was not dependent upon activity of mature T cells, since the same result was seen in athymic nude mice. The difference was partially sensitive to irradiation of the hosts. When mice were pretreated with anti-asialo GM1 antiserum, known to depress natural killer (NK) cell activity, the difference in outgrowth was abolished, and both the control line and the H-2- variant showed progressive growth in vivo. Experiments comparing the distribution and survival of isotope-prelabeled variant and wild type cells indicated that a rapid elimination of the former took place within 24 h after intravenous injection. These differences in tumor elimination were not seen in mice treated with anti-asialo GM1 antiserum. We conclude that the reduced tumorigenicity of sublines with impaired H-2 expression is largely, if not exclusively due to rapid elimination by NK cells. These findings may reflect an inverse, indirect relation between factors controlling H-2 expression and NK sensitivity. Another possible explanation is that major histocompatibility complex (MHC)-encoded gene products are directly involved in a regulatory signal in the NK cell system. According to this interpretation, immunological selectivity in the NK cell system would be achieved by the failure to recognize self- MHC, irrespective of the presence of foreign antigens, i.e. by detection of no-self rather than of nonself. This may also explain previous observations on H-2-linked hybrid resistance against lymphoid grafts and changes in H-2 phenotypes associated with tumor progression.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., Raulet, D. H. (2009). NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model. J. Immunol. 182: 4572-4580 [Abstract] [Full Text]
Mailloux, A. W., Young, M. R. I. (2009). NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment. J. Immunol. 182: 2753-2765 [Abstract] [Full Text]
Aguilo, J. I., Garaude, J., Pardo, J., Villalba, M., Anel, A. (2009). Protein Kinase C-{theta} Is Required for NK Cell Activation and In Vivo Control of Tumor Progression. J. Immunol. 182: 1972-1981 [Abstract] [Full Text]
Halfteck, G. G., Elboim, M., Gur, C., Achdout, H., Ghadially, H., Mandelboim, O. (2009). Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1. J. Immunol. 182: 2221-2230 [Abstract] [Full Text]
Gasparri, A. M., Jachetti, E., Colombo, B., Sacchi, A., Curnis, F., Rizzardi, G.-P., Traversari, C., Bellone, M., Corti, A. (2008). Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFN{gamma}. Molecular Cancer Therapeutics 7: 3859-3866 [Abstract] [Full Text]
Curnis, F., Sacchi, A., Gasparri, A., Longhi, R., Bachi, A., Doglioni, C., Bordignon, C., Traversari, C., Rizzardi, G.-P., Corti, A. (2008). Isoaspartate-Glycine-Arginine: A New Tumor Vasculature-Targeting Motif. Cancer Res. 68: 7073-7082 [Abstract] [Full Text]
Chlewicki, L. K., Velikovsky, C. A., Balakrishnan, V., Mariuzza, R. A., Kumar, V. (2008). Molecular Basis of the Dual Functions of 2B4 (CD244). J. Immunol. 180: 8159-8167 [Abstract] [Full Text]
Degl'Innocenti, E., Grioni, M., Capuano, G., Jachetti, E., Freschi, M., Bertilaccio, M. T.S., Hess-Michelini, R., Doglioni, C., Bellone, M. (2008). Peripheral T-Cell Tolerance Associated with Prostate Cancer Is Independent from CD4+CD25+ Regulatory T Cells. Cancer Res. 68: 292-300 [Abstract] [Full Text]
Yachi, P. P., Lotz, C., Ampudia, J., Gascoigne, N. R.J. (2007). T cell activation enhancement by endogenous pMHC acts for both weak and strong agonists but varies with differentiation state. JEM 204: 2747-2757 [Abstract] [Full Text]
Banerjee, P., Feuer, G., Barker, E. (2007). Human T-Cell Leukemia Virus Type 1 (HTLV-1) p12I Down-Modulates ICAM-1 and -2 and Reduces Adherence of Natural Killer Cells, Thereby Protecting HTLV-1-Infected Primary CD4+ T Cells from Autologous Natural Killer Cell-Mediated Cytotoxicity despite the Reduction of Major Histocompatibility Complex Class I Molecules on Infected Cells. J. Virol. 81: 9707-9717 [Abstract] [Full Text]
Malarkannan, S., Regunathan, J., Chu, H., Kutlesa, S., Chen, Y., Zeng, H., Wen, R., Wang, D. (2007). Bcl10 Plays a Divergent Role in NK Cell-Mediated Cytotoxicity and Cytokine Generation. J. Immunol. 179: 3752-3762 [Abstract] [Full Text]
Tiwari, N., Garbi, N., Reinheckel, T., Moldenhauer, G., Hammerling, G. J., Momburg, F. (2007). A Transporter Associated with Antigen-Processing Independent Vacuolar Pathway for the MHC Class I-Mediated Presentation of Endogenous Transmembrane Proteins. J. Immunol. 178: 7932-7942 [Abstract] [Full Text]
Hiss, J. A., Bredenbeck, A., Losch, F. O., Wrede, P., Walden, P., Schneider, G. (2007). Design of MHC I stabilizing peptides by agent-based exploration of sequence space. Protein Eng Des Sel 20: 99-108 [Abstract] [Full Text]
Curnis, F., Longhi, R., Crippa, L., Cattaneo, A., Dondossola, E., Bachi, A., Corti, A. (2006). Spontaneous Formation of L-Isoaspartate and Gain of Function in Fibronectin. J. Biol. Chem. 281: 36466-36476 [Abstract] [Full Text]
Regunathan, J., Chen, Y., Kutlesa, S., Dai, X., Bai, L., Wen, R., Wang, D., Malarkannan, S. (2006). Differential and Nonredundant Roles of Phospholipase C{gamma}2 and Phospholipase C{gamma}1 in the Terminal Maturation of NK Cells. J. Immunol. 177: 5365-5376 [Abstract] [Full Text]
Ferreira, C., Furmanski, A., Millrain, M., Bartok, I., Guillaume, P., Lees, R., Simpson, E., MacDonald, H. R., Dyson, J. (2006). TCR-{alpha} CDR3 Loop Audition Regulates Positive Selection. J. Immunol. 177: 2477-2485 [Abstract] [Full Text]
Margalit, A., Sheikhet, H. M., Carmi, Y., Berko, D., Tzehoval, E., Eisenbach, L., Gross, G. (2006). Induction of Antitumor Immunity by CTL Epitopes Genetically Linked to Membrane-Anchored {beta}2-Microglobulin. J. Immunol. 176: 217-224 [Abstract] [Full Text]
Poggi, A., Prevosto, C., Massaro, A.-M., Negrini, S., Urbani, S., Pierri, I., Saccardi, R., Gobbi, M., Zocchi, M. R. (2005). Interaction between Human NK Cells and Bone Marrow Stromal Cells Induces NK Cell Triggering: Role of NKp30 and NKG2D Receptors. J. Immunol. 175: 6352-6360 [Abstract] [Full Text]
Wettstein, P. J., Borson, N. D., Park, J. G., McNallan, K. T., Reed, A. M. (2005). Cysteine-Tailed Class I-Binding Peptides Bind to CpG Adjuvant and Enhance Primary CTL Responses. J. Immunol. 175: 3681-3689 [Abstract] [Full Text]
Zhang, T., Lemoi, B. A., Sentman, C. L. (2005). Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy. Blood 106: 1544-1551 [Abstract] [Full Text]
Wooden, S. L., Kalb, S. R., Cotter, R. J., Soloski, M. J. (2005). Cutting Edge: HLA-E Binds a Peptide Derived from the ATP-Binding Cassette Transporter Multidrug Resistance-Associated Protein 7 aSnd Inhibits NK Cell-Mediated Lysis. J. Immunol. 175: 1383-1387 [Abstract] [Full Text]
Sesma, L., Galocha, B., Vazquez, M., Purcell, A. W., Marcilla, M., McCluskey, J., de Castro, J. A. L. (2005). Qualitative and Quantitative Differences in Peptides Bound to HLA-B27 in the Presence of Mouse versus Human Tapasin Define a Role for Tapasin as a Size-Dependent Peptide Editor. J. Immunol. 174: 7833-7844 [Abstract] [Full Text]
Chiang, E. Y., Stroynowski, I. (2005). Protective Immunity against Disparate Tumors Is Mediated by a Nonpolymorphic MHC Class I Molecule. J. Immunol. 174: 5367-5374 [Abstract] [Full Text]
Curnis, F., Gasparri, A., Sacchi, A., Cattaneo, A., Magni, F., Corti, A. (2005). Targeted Delivery of IFN{gamma} to Tumor Vessels Uncouples Antitumor from Counterregulatory Mechanisms. Cancer Res. 65: 2906-2913 [Abstract] [Full Text]
Casati, A., Zimmermann, V. S., Benigni, F., Bertilaccio, M. T. S., Bellone, M., Mondino, A. (2005). The Immunogenicity of Dendritic Cell-Based Vaccines Is Not Hampered by Doxorubicin and Melphalan Administration. J. Immunol. 174: 3317-3325 [Abstract] [Full Text]
Berko, D., Carmi, Y., Cafri, G., Ben-Zaken, S., Sheikhet, H. M., Tzehoval, E., Eisenbach, L., Margalit, A., Gross, G. (2005). Membrane-Anchored {beta}2-Microglobulin Stabilizes a Highly Receptive State of MHC Class I Molecules. J. Immunol. 174: 2116-2123 [Abstract] [Full Text]
Munz, C., Dao, T., Ferlazzo, G., de Cos, M. A., Goodman, K., Young, J. W. (2005). Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 105: 266-273 [Abstract] [Full Text]
Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B., Cambi, A., Figdor, C., Vainchenker, W., Galy, A., Caignard, A., Zitvogel, L. (2004). NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267-3275 [Abstract] [Full Text]
Bendle, G. M., Holler, A., Pang, L.-K., Hsu, S., Krampera, M., Simpson, E., Stauss, H. J. (2004). Induction of Unresponsiveness Limits Tumor Protection by Adoptively Transferred MDM2-Specific Cytotoxic T Lymphocytes. Cancer Res. 64: 8052-8056 [Abstract] [Full Text]
Schell, T. D. (2004). In Vivo Expansion of the Residual Tumor Antigen-Specific CD8+ T Lymphocytes That Survive Negative Selection in Simian Virus 40 T-Antigen-Transgenic Mice. J. Virol. 78: 1751-1762 [Abstract] [Full Text]
Ramirez, F., Ghani, Y., Stauss, H. (2004). Incomplete tolerance to the tumour-associated antigen MDM2. Int Immunol 16: 327-334 [Abstract] [Full Text]
Curnis, F., Gasparri, A., Sacchi, A., Longhi, R., Corti, A. (2004). Coupling Tumor Necrosis Factor-{alpha} with {alpha}V Integrin Ligands Improves Its Antineoplastic Activity. Cancer Res. 64: 565-571 [Abstract] [Full Text]
Hayakawa, Y., Screpanti, V., Yagita, H., Grandien, A., Ljunggren, H.-G., Smyth, M. J., Chambers, B. J. (2004). NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy. J. Immunol. 172: 123-129 [Abstract] [Full Text]
Tegerstedt, K., Andreasson, K., Vlastos, A., Hedlund, K. O., Dalianis, T., Ramqvist, T. (2003). Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs. J. Gen. Virol. 84: 3443-3452 [Abstract] [Full Text]
Foster, C. E., Colonna, M., Sun, P. D. (2003). Crystal Structure of the Human Natural Killer (NK) Cell Activating Receptor NKp46 Reveals Structural Relationship to Other Leukocyte Receptor Complex Immunoreceptors. J. Biol. Chem. 278: 46081-46086 [Abstract] [Full Text]
Schott, E., Bonasio, R., Ploegh, H. L. (2003). Elimination In Vivo of Developing T Cells by Natural Killer Cells. JEM 198: 1213-1224 [Abstract] [Full Text]
Lonsdorf, A. S., Kuekrek, H., Stern, B. V., Boehm, B. O., Lehmann, P. V., Tary-Lehmann, M. (2003). Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity. J. Immunol. 171: 3941-3946 [Abstract] [Full Text]
Tajima, A., Tanaka, T., Ebata, T., Takeda, K., Kawasaki, A., Kelly, J. M., Darcy, P. K., Vance, R. E., Raulet, D. H., Kinoshita, K., Okumura, K., Smyth, M. J., Yagita, H. (2003). Blastocyst MHC, a Putative Murine Homologue of HLA-G, Protects TAP-Deficient Tumor Cells from Natural Killer Cell-Mediated Rejection In Vivo. J. Immunol. 171: 1715-1721 [Abstract] [Full Text]
Zhao, Y., Ohdan, H., Manilay, J. O., Sykes, M. (2003). NK Cell Tolerance in Mixed Allogeneic Chimeras. J. Immunol. 170: 5398-5405 [Abstract] [Full Text]
Lodoen, M., Ogasawara, K., Hamerman, J. A., Arase, H., Houchins, J. P., Mocarski, E. S., Lanier, L. L. (2003). NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules. JEM 197: 1245-1253 [Abstract] [Full Text]
Ohlschlager, P., Osen, W., Dell, K., Faath, S., Garcea, R. L., Jochmus, I., Muller, M., Pawlita, M., Schafer, K., Sehr, P., Staib, C., Sutter, G., Gissmann, L. (2003). Human Papillomavirus Type 16 L1 Capsomeres Induce L1-Specific Cytotoxic T Lymphocytes and Tumor Regression in C57BL/6 Mice. J. Virol. 77: 4635-4645 [Abstract] [Full Text]
Stebbing, J., Bourboulia, D., Johnson, M., Henderson, S., Williams, I., Wilder, N., Tyrer, M., Youle, M., Imami, N., Kobu, T., Kuon, W., Sieper, J., Gotch, F., Boshoff, C. (2003). Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes. J. Virol. 77: 4306-4314 [Abstract] [Full Text]
Yang, T.-H., Lovatt, M., Merkenschlager, M., Stauss, H. J. (2002). Comparison of the frequency of peptide-specific cytotoxic T lymphocytes restricted by self- and allo-MHC following in vitro T cell priming. Int Immunol 14: 1283-1290 [Abstract] [Full Text]
Ramos, M., Alvarez, I., Sesma, L., Logean, A., Rognan, D., Lopez de Castro, J. A. (2002). Molecular Mimicry of an HLA-B27-derived Ligand of Arthritis-linked Subtypes with Chlamydial Proteins. J. Biol. Chem. 277: 37573-37581 [Abstract] [Full Text]
Applequist, S. E., Wallin, R. P. A., Ljunggren, H.-G. (2002). Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 14: 1065-1074 [Abstract] [Full Text]
Wizel, B., Starcher, B. C., Samten, B., Chroneos, Z., Barnes, P. F., Dzuris, J., Higashimoto, Y., Appella, E., Sette, A. (2002). Multiple Chlamydiapneumoniae Antigens Prime CD8+ Tc1 Responses That Inhibit Intracellular Growth of This Vacuolar Pathogen. J. Immunol. 169: 2524-2535 [Abstract] [Full Text]
Ramos, M., Paradela, A., Vazquez, M., Marina, A., Vazquez, J., Lopez de Castro, J. A. (2002). Differential Association of HLA-B*2705 and B*2709 to Ankylosing Spondylitis Correlates with Limited Peptide Subsets but Not with Altered Cell Surface Stability. J. Biol. Chem. 277: 28749-28756 [Abstract] [Full Text]
Stern, B. V., Boehm, B. O., Tary-Lehmann, M. (2002). Vaccination with Tumor Peptide in CpG Adjuvant Protects Via IFN-{gamma}-Dependent CD4 Cell Immunity. J. Immunol. 168: 6099-6105 [Abstract] [Full Text]
Sesma, L., Montserrat, V., Lamas, J. R., Marina, A., Vazquez, J., de Castro, J. A. L. (2002). The Peptide Repertoires of HLA-B27 Subtypes Differentially Associated to Spondyloarthropathy (B*2704 and B*2706) Differ by Specific Changes at Three Anchor Positions. J. Biol. Chem. 277: 16744-16749 [Abstract] [Full Text]
Egilmez, N. K., Hess, S. D., Chen, F.-A., Takita, H., Conway, T. F., Bankert, R. B. (2002). Human CD4+ Effector T Cells Mediate Indirect Interleukin-12- and Interferon-{gamma}-dependent Suppression of Autologous HLA-negative Lung Tumor Xenografts in Severe Combined Immunodeficient Mice. Cancer Res. 62: 2611-2617 [Abstract] [Full Text]
Kelly, J. M., Takeda, K., Darcy, P. K., Yagita, H., Smyth, M. J. (2002). A Role for IFN-{gamma} in Primary and Secondary Immunity Generated by NK Cell-Sensitive Tumor-Expressing CD80 In Vivo. J. Immunol. 168: 4472-4479 [Abstract] [Full Text]
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., Munz, C. (2002). Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells. JEM 195: 343-351 [Abstract] [Full Text]
Curnis, F., Arrigoni, G., Sacchi, A., Fischetti, L., Arap, W., Pasqualini, R., Corti, A. (2002). Differential Binding of Drugs Containing the NGR Motif to CD13 Isoforms in Tumor Vessels, Epithelia, and Myeloid Cells. Cancer Res. 62: 867-874 [Abstract] [Full Text]
Castiglioni, P., Martin-Fontecha, A., Milan, G., Tomajer, V., Magni, F., Michaelsson, J., Rugarli, C., Rosato, A., Bellone, M. (2002). Apoptosis-dependent Subversion of the T-Lymphocyte Epitope Hierarchy in Lymphoma Cells. Cancer Res. 62: 1116-1122 [Abstract] [Full Text]
Schell, T. D., Tevethia, S. S. (2001). Control of Advanced Choroid Plexus Tumors in SV40 T Antigen Transgenic Mice Following Priming of Donor CD8+ T Lymphocytes by the Endogenous Tumor Antigen. J. Immunol. 167: 6947-6956 [Abstract] [Full Text]
Seliger, B., Ritz, U., Abele, R., Bock, M., Tampe, R., Sutter, G., Drexler, I., Huber, C., Ferrone, S. (2001). Immune Escape of Melanoma: First Evidence of Structural Alterations in Two Distinct Components of the MHC Class I Antigen Processing Pathway. Cancer Res. 61: 8647-8650 [Abstract] [Full Text]
Yague, J., Marina, A., Vazquez, J., Lopez de Castro, J. A. (2001). Major Histocompatibility Complex Class I Molecules Bind Natural Peptide Ligands Lacking the Amino-terminal Binding Residue in Vivo. J. Biol. Chem. 276: 43699-43707 [Abstract] [Full Text]
Kuon, W., Holzhutter, H.-G., Appel, H., Grolms, M., Kollnberger, S., Traeder, A., Henklein, P., Weiss, E., Thiel, A., Lauster, R., Bowness, P., Radbruch, A., Kloetzel, P.-M., Sieper, J. (2001). Identification of HLA-B27-Restricted Peptides from the Chlamydia trachomatis Proteome with Possible Relevance to HLA-B27-Associated Diseases. J. Immunol. 167: 4738-4746 [Abstract] [Full Text]
Screpanti, V., Wallin, R. P. A., Ljunggren, H.-G., Grandien, A. (2001). A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells. J. Immunol. 167: 2068-2073 [Abstract] [Full Text]
Michaelsson, J., Achour, A., Rolle, A., Karre, K. (2001). MHC Class I Recognition by NK Receptors in the Ly49 Family Is Strongly Influenced by the {{beta}}2-Microglobulin Subunit. J. Immunol. 166: 7327-7334 [Abstract] [Full Text]
Seliger, B., Wollscheid, U., Momburg, F., Blankenstein, T., Huber, C. (2001). Characterization of the Major Histocompatibility Complex Class I Deficiencies in B16 Melanoma Cells. Cancer Res. 61: 1095-1099 [Abstract] [Full Text]
van Bergen, J., Camps, M., Offringa, R., Melief, C. J. M., Ossendorp, F., Koning, F. (2000). Superior Tumor Protection Induced by a Cellular Vaccine Carrying a Tumor-specific T Helper Epitope by Genetic Exchange of the Class II-associated Invariant Chain Peptide. Cancer Res. 60: 6427-6433 [Abstract] [Full Text]
Lee, K. H., Ono, M., Inui, M., Yuasa, T., Takai, T. (2000). Stimulatory Function of gp49A, a Murine Ig-Like Receptor, in Rat Basophilic Leukemia Cells. J. Immunol. 165: 4970-4977 [Abstract] [Full Text]
Ober, B. T., Hu, Q., Opferman, J. T., Hagevik, S., Chiu, N., Wang, C.-R., Ashton-Rickardt, P. G. (2000). Affinity of thymic self-peptides for the TCR determines the selection of CD8+ T lymphocytes in the thymus. Int Immunol 12: 1353-1363 [Abstract] [Full Text]
Brawand, P., Lemonnier, F. A., MacDonald, H. R., Cerottini, J.-C., Held, W. (2000). Transgenic Expression of Ly49A on T Cells Impairs a Specific Antitumor Response. J. Immunol. 165: 1871-1876 [Abstract] [Full Text]
Mylin, L. M., Schell, T. D., Roberts, D., Epler, M., Boesteanu, A., Collins, E. J., Frelinger, J. A., Joyce, S., Tevethia, S. S. (2000). Quantitation of CD8+ T-Lymphocyte Responses to Multiple Epitopes from Simian Virus 40 (SV40) Large T Antigen in C57BL/6 Mice Immunized with SV40, SV40 T-Antigen-Transformed Cells, or Vaccinia Virus Recombinants Expressing Full-Length T Antigen or Epitope Minigenes. J. Virol. 74: 6922-6934 [Abstract] [Full Text]
Guttinger, M., Guidi, F., Chinol, M., Reali, E., Veglia, F., Viale, G., Paganelli, G., Corti, A., Siccardi, A. G. (2000). Adoptive Immunotherapy by Avidin-driven Cytotoxic T Lymphocyte- Tumor Bridging. Cancer Res. 60: 4211-4215 [Abstract] [Full Text]
Sandberg, J. K., Franksson, L., Sundback, J., Michaelsson, J., Petersson, M., Achour, A., Wallin, R. P. A., Sherman, N. E., Bergman, T., Jornvall, H., Hunt, D. F., Kiessling, R., Karre, K. (2000). T Cell Tolerance Based on Avidity Thresholds Rather Than Complete Deletion Allows Maintenance of Maximal Repertoire Diversity. J. Immunol. 165: 25-33 [Abstract] [Full Text]
Yague, J., Alvarez, I., Rognan, D., Ramos, M., Vazquez, J., de Castro, J. A. L. (2000). An N-Acetylated Natural Ligand of Human Histocompatibility Leukocyte Antigen (Hla)-B39: Classical Major Histocompatibility Complex Class I Proteins Bind Peptides with a Blocked Nh2 Terminus in Vivo. JEM 191: 2083-2092 [Abstract] [Full Text]
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., Lindberg, F. P. (2000). Role of CD47 as a Marker of Self on Red Blood Cells. Science 288: 2051-2054 [Abstract] [Full Text]
Schell, T. D., Knowles, B. B., Tevethia, S. S. (2000). Sequential Loss of Cytotoxic T Lymphocyte Responses to Simian Virus 40 Large T Antigen Epitopes in T Antigen Transgenic Mice Developing Osteosarcomas. Cancer Res. 60: 3002-3012 [Abstract] [Full Text]
Oka, Y., Udaka, K., Tsuboi, A., Elisseeva, O. A., Ogawa, H., Aozasa, K., Kishimoto, T., Sugiyama, H. (2000). Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product. J. Immunol. 164: 1873-1880 [Abstract] [Full Text]
Glas, R., Franksson, L., Une, C., Eloranta, M.-L., Ohlen, C., Orn, A., Karre, K. (2000). Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype: An Adaptive Component of Nk Cell-Mediated Responses. JEM 191: 129-138 [Abstract] [Full Text]
Paradela, A., Alvarez, I., Garcia-Peydro, M., Sesma, L., Ramos, M., Vazquez, J., Lopez de Castro, J. A. (2000). Limited Diversity of Peptides Related to an Alloreactive T Cell Epitope in the HLA-B27-Bound Peptide Repertoire Results from Restrictions at Multiple Steps Along the Processing-Loading Pathway. J. Immunol. 164: 329-337 [Abstract] [Full Text]
Garcia-Peydro, M., Paradela, A., Lamas, J. R., Lopez de Castro, J. A. (1999). Peptide Presentation to an Alloreactive CTL Clone Is Modulated Through Multiple Mechanisms Involving Polymorphic and Conserved Residues in HLA-B27. J. Immunol. 163: 6060-6064 [Abstract] [Full Text]
Gao, L., Yang, T.-H., Tourdot, S., Sadovnikova, E., Hasserjian, R., Stauss, H. J. (1999). Allo-Major Histocompatibility Complex-Restricted Cytotoxic T Lymphocytes Engraft in Bone Marrow Transplant Recipients Without Causing Graft-Versus-Host Disease. Blood 94: 2999-3006 [Abstract] [Full Text]
Hin, S., Zabel, C., Bianco, A., Jung, G., Walden, P. (1999). Cutting Edge: N-Hydroxy Peptides: A New Class of TCR Antagonists. J. Immunol. 163: 2363-2367 [Abstract] [Full Text]
Cretney, E., Degli-Esposti, M. A., Densley, E. H., Farrell, H. E., Davis-Poynter, N. J., Smyth, M. J. (1999). M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell-Mediated Rejection. JEM 190: 435-444 [Abstract] [Full Text]
Schell, T. D., Mylin, L. M., Georgoff, I., Teresky, A. K., Levine, A. J., Tevethia, S. S. (1999). Cytotoxic T-Lymphocyte Epitope Immunodominance in the Control of Choroid Plexus Tumors in Simian Virus 40�Large T Antigen Transgenic Mice. J. Virol. 73: 5981-5993 [Abstract] [Full Text]
Hauser, C., Zipprich, F., Leblond, I., Wirth, S., Hugin, A. W. (1999). Protective Immunity from Naive CD8+ T Cells Activated In Vitro with MHC Class I Binding Immunogenic Peptides and IL-2 in the Absence of Specialized APCs. J. Immunol. 163: 330-336 [Abstract] [Full Text]
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., Scalzo, A. A. (1999). Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis. J. Immunol. 162: 6658-6662 [Abstract] [Full Text]
Martin-Fontecha, A., Assarsson, E., Carbone, E., Karre, K., Ljunggren, H.-G. (1999). Triggering of Murine NK Cells by CD40 and CD86 (B7-2). J. Immunol. 162: 5910-5916 [Abstract] [Full Text]
Saito, N. G., Chang, H.-C., Paterson, Y. (1999). Recognition of an MHC Class I-Restricted Antigenic Peptide Can Be Modulated by para-Substitution of Its Buried Tyrosine Residues in a TCR-Specific Manner. J. Immunol. 162: 5998-6008 [Abstract] [Full Text]
Pestano, G. A., Zhou, Y., Trimble, L. A., Daley, J., Weber, G. F., Cantor, H. (1999). Inactivation of Misselected CD8 T Cells by CD8 Gene Methylation and Cell Death. Science 284: 1187-1191 [Abstract] [Full Text]
Owen, B. A. L., Pease, L. R. (1999). TAP Association Influences the Conformation of Nascent MHC Class I Molecules. J. Immunol. 162: 4677-4684 [Abstract] [Full Text]
Zhou, X., Wong, S., Walter, J., Jacks, T., Eisen, H. N. (1999). Increased Generation of CD8+ T Cell Clones in p53 Mutant Mice. J. Immunol. 162: 3957-3960 [Abstract] [Full Text]
Sandberg, J. K., Karre, K., Glas, R. (1999). Recognition of the Major Histocompatibility Complex Restriction Element Modulates CD8+ T Cell Specificity and Compensates for Loss of T Cell Receptor Contacts with the Specific Peptide. JEM 189: 883-894 [Abstract] [Full Text]
Mylin, L. M. (1999). Context-Dependent Immunogenicity of an S206G-Substituted H-2Db-Restricted Simian Virus 40 Large T Antigen Epitope I Variant. J. Immunol. 162: 2171-2179 [Abstract] [Full Text]
Kase, A., Johansson, M. H., Olsson-Alheim, M. Y., Karre, K., Hoglund, P. (1998). External and Internal Calibration of the MHC Class I-Specific Receptor Ly49A on Murine Natural Killer Cells. J. Immunol. 161: 6133-6138 [Abstract] [Full Text]
Dabhi, V. M., Hovik, R., Van Kaer, L., Fischer Lindahl, K. (1998). The Alloreactive T Cell Response Against the Class Ib Molecule H2-M3 Is Specific for High Affinity Peptides. J. Immunol. 161: 5171-5178 [Abstract] [Full Text]
Dyall, R., Bowne, W. B., Weber, L. W., LeMaoult, J., Szabo, P., Moroi, Y., Piskun, G., Lewis, J. J., Houghton, A. N., Nikolic-Zugic, J. (1998). Heteroclitic Immunization Induces Tumor Immunity. JEM 188: 1553-1561 [Abstract] [Full Text]
Smyth, M. J., Kelly, J. M., Baxter, A. G., Korner, H., Sedgwick, J. D. (1998). An Essential Role for Tumor Necrosis Factor in Natural Killer Cell-mediated Tumor Rejection in the Peritoneum. JEM 188: 1611-1619 [Abstract] [Full Text]
Rüssmann, H., Shams, H., Poblete, F., Fu, Y., Galán, J. E., Donis, R. O. (1998). Delivery of Epitopes by the Salmonella Type III Secretion System for Vaccine Development. Science 281: 565-568 [Abstract] [Full Text]
Smyth, M. J., Krasovskis, E., Johnstone, R. W. (1998). Fas Ligand-Mediated Lysis of Self Bystander Targets by Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes. J. Virol. 72: 5948-5954 [Abstract] [Full Text]
Rigney, E., Kojima, M., Glithero, A., Elliott, T. (1998). A Soluble Major Histocompatibility Complex Class I Peptide-binding Platform Undergoes a Conformational Change in Response to Peptide Epitopes. J. Biol. Chem. 273: 14200-14204 [Abstract] [Full Text]
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M., Geraghty, D. E. (1998). HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95: 5199-5204 [Abstract] [Full Text]
Sandberg, J. K., Grufman, P., Wolpert, E. Z., Franksson, L., Chambers, B. J., Karre, K. (1998). Superdominance Among Immunodominant H-2Kb-Restricted Epitopes and Reversal by Dendritic Cell-Mediated Antigen Delivery. J. Immunol. 160: 3163-3169 [Abstract] [Full Text]
Markiewicz, M. A., Girao, C., Opferman, J. T., Sun, J., Hu, Q., Agulnik, A. A., Bishop, C. E., Thompson, C. B., Ashton-Rickardt, P. G. (1998). Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 95: 3065-3070 [Abstract] [Full Text]